RAMAZZOTTI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 4.721
AS - Asia 4.077
EU - Europa 3.627
AF - Africa 375
SA - Sud America 217
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.034
Nazione #
US - Stati Uniti d'America 4.667
SG - Singapore 1.260
VN - Vietnam 1.026
IT - Italia 1.023
CN - Cina 987
GB - Regno Unito 617
DE - Germania 484
SE - Svezia 448
HK - Hong Kong 240
FR - Francia 195
IN - India 172
RU - Federazione Russa 168
BR - Brasile 142
UA - Ucraina 114
IE - Irlanda 113
TG - Togo 109
KR - Corea 102
NL - Olanda 87
FI - Finlandia 81
CI - Costa d'Avorio 76
ZA - Sudafrica 67
JP - Giappone 63
SC - Seychelles 56
CH - Svizzera 44
EE - Estonia 41
BG - Bulgaria 40
AT - Austria 39
NG - Nigeria 38
CA - Canada 34
HR - Croazia 31
AR - Argentina 30
PK - Pakistan 27
BE - Belgio 24
ID - Indonesia 24
PH - Filippine 23
JO - Giordania 21
PL - Polonia 21
BD - Bangladesh 18
TH - Thailandia 18
IQ - Iraq 16
GR - Grecia 13
RO - Romania 12
TR - Turchia 12
ES - Italia 10
MX - Messico 10
TW - Taiwan 10
UY - Uruguay 10
MY - Malesia 8
UZ - Uzbekistan 8
CO - Colombia 7
EC - Ecuador 7
AU - Australia 6
CL - Cile 6
SA - Arabia Saudita 6
NZ - Nuova Zelanda 5
PE - Perù 5
TN - Tunisia 5
VE - Venezuela 5
IL - Israele 4
KE - Kenya 4
KZ - Kazakistan 4
LB - Libano 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
DZ - Algeria 3
EG - Egitto 3
ET - Etiopia 3
LT - Lituania 3
MA - Marocco 3
MD - Moldavia 3
PS - Palestinian Territory 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
BW - Botswana 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
IR - Iran 2
JM - Giamaica 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SS - ???statistics.table.value.countryCode.SS??? 2
SV - El Salvador 2
AO - Angola 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
KW - Kuwait 1
LK - Sri Lanka 1
Totale 13.024
Città #
Singapore 888
Ashburn 520
Southend 519
Chandler 429
Fairfield 427
Bologna 347
Santa Clara 248
Houston 236
Ho Chi Minh City 226
Hong Kong 225
Hanoi 197
San Jose 194
Woodbridge 185
Ann Arbor 184
Hefei 180
Seattle 177
Cambridge 157
Wilmington 157
Princeton 138
Beijing 129
Boardman 114
Dublin 113
Dallas 112
Lomé 109
Dong Ket 102
Abidjan 76
Frankfurt am Main 71
Seoul 69
Lauterbourg 68
Jacksonville 63
New York 63
Westminster 56
Helsinki 53
Nanjing 53
Milan 52
Los Angeles 50
Tokyo 50
Padova 49
Berlin 45
Sofia 40
Munich 38
Bern 37
San Diego 37
Florence 36
Abeokuta 35
Council Bluffs 35
Buffalo 33
Moscow 33
Turin 33
Jinan 32
Saint Petersburg 32
Haiphong 29
Redondo Beach 29
Guangzhou 28
São Paulo 28
Da Nang 26
Vienna 26
Changsha 25
Redwood City 25
Johannesburg 24
Redmond 24
Shenyang 24
Brussels 23
Rome 23
Bremen 22
Des Moines 22
Shanghai 22
Amman 20
Parma 19
San Francisco 19
London 18
Sejong 18
Medford 16
Nanchang 16
Udine 16
Chicago 15
Warsaw 15
Bengaluru 14
Jakarta 14
Lappeenranta 14
Turku 14
Zhengzhou 14
Kunming 13
Tianjin 13
Toronto 13
Biên Hòa 12
Nuremberg 12
Orem 12
Paris 12
The Dalles 12
Hangzhou 11
Hebei 11
Mountain View 11
Atlanta 10
Dearborn 10
Falkenstein 10
Mülheim 10
Rawalpindi 10
Verona 10
Boston 9
Totale 8.395
Nome #
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes 341
Lamin A and prelamin A counteract invasiveness of osteosarcoma cells 269
Impact of phospholipase C β1 in glioblastoma: a study on the main mechanisms of tumor aggressiveness 249
Inositide-Dependent Nuclear Signalling in Health and Disease 245
A role for PKCepsilon during C2C12 myogenic differentiation 237
K562 cell proliferation is modulated by PLCbeta1 through a PKCalpha-mediated pathway 230
Cancer therapy and treatments during COVID-19 era 229
BMP-2 Induced Expression of PLCβ1 That is a Positive Regulator of Osteoblast Differentiation 221
Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes 219
Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. 218
PLC-β1 and cell differentiation: An insight into myogenesis and osteogenesis 207
Nuclear inositide signaling and cell cycle 207
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 206
Role of PLCγ1 in the modulation of cell migration and cell invasion in glioblastoma 206
An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes 205
Nuclear phospholipase C isoenzyme imbalance leads to pathologies in brain, hematologic, neuromuscular, and fertility disorders 203
Nuclear Inositide Signaling via Phospholipase C 201
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells. 201
Phospholipases in Gliomas: Current Knowledge and Future Perspectives from Bench to Bedside 198
Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS 197
Aberrant expression of B203.13 antigen in acute lymphoid leukemia of B-cell origin. 197
Lamin B1 accumulation’s effects on autosomal dominant leukodystrophy (ADLD): Induction of reactivity in the astrocytes 197
Location-dependent role of phospholipase C signaling in the brain: Physiology and pathology 195
Revisiting nuclear phospholipase C signalling in MDS 194
The wide and growing range of lamin B‑related diseases: from laminopathies to cancer 194
Genotype of inflammatory cytokines in limbal stem cell graft in Italian patients. 189
Epigenetic regulation of nuclear inositide signalling in high-risk MDS patients 186
IPMK and β-catenin mediate PLC-β1-dependent signaling in myogenic differentiation 186
Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes 184
Inositide signaling in the nucleus: From physiology to pathology. 183
Phosphoinositide-dependent signaling in cancer: A focus on phospholipase C isozymes 183
Therapeutic potential of nvp-bkm120 in human osteosarcomas cells 181
Subcellular localization relevance and cancer-associated mechanisms of diacylglycerol kinases 181
eEF1A phosphorylation in the nucleus of insulin-stimulated C2C12 myoblasts: Ser53 is a novel substrate for protein kinase C βI 178
Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome. 178
Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins. 178
Phospholipase C-β1 interacts with cyclin E in adipose- derived stem cells osteogenic differentiation 176
Advances in MDS/AML and inositide signalling 174
Structural Variants at the LMNB1 Locus: Deciphering Pathomechanisms in Autosomal Dominant Adult-Onset Demyelinating Leukodystrophy 173
Nuclear phospholipase C beta1 and cellular differentiation. 172
Physiology and pathology of nuclear phospholipase C beta1 172
MiRNA-210: A Current Overview 172
Nuclear PI-PLCβ1 and Myelodysplastic Syndromes: Genetics and Epigenetics 171
Signaling pathways and bone marrow microenvironment in myelodysplastic neoplasms 169
Nuclear Phosphatidylinositol Signaling: Focus on Phosphatidylinositol Phosphate Kinases and Phospholipases C 169
Lamin B1 as a key modulator of the developing and aging brain 168
Inositide-dependent phospholipase C signaling mimics insulin in skeletal muscle differentiation by affecting specific regions of the cyclin D3 promoter 165
Roles of PI3K/AKT/mTOR Axis in Arteriovenous Fistula 163
Involvement of nuclear PLC{beta}1 in lamin B1 phosphorylation and G2/M cell cycle progression. 162
Nuclear Phosphoinositides as Key Determinants of Nuclear Functions 161
PLC-beta 1 regulates the expression of miR-210 during mithramycin-mediated erythroid differentiation in K562 cells 160
Epigenetic regulation of nuclear PLCbeta1 and Cyclin D3 during Azacitidine treatment 159
Phosphoinositide 3 Kinase signaling in human stem cells from reprogramming to differentiation: A tale in cytoplasmic and nuclear compartments 159
Modulation of nuclear PI-PLCbeta1 during cell differentiation 155
Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes 152
Nuclear inositide signaling in myelodysplastic syndromes. 151
The physiology and pathology of inositide signaling in the nucleus 151
Understanding the Ultra-Rare Disease Autosomal Dominant Leukodystrophy: an Updated Review on Morpho-Functional Alterations Found in Experimental Models 149
A novel DAG-dependent mechanism links PKCɑ and Cyclin B1 regulating cell cycle progression 149
Nuclear translocation of PKCα isoenzyme is involved in neurogenic commitment of human neural crest-derived periodontal ligament stem cells 147
Nuclear PI-PLCbeta1-Lamin B1 complex signalling during cell cycle progression in human erytholeukemia cells 146
Recent advances in MDS mutation landscape: Splicing and signalling 146
null 144
Role of nuclear PLC and PI3K signaling in the development of cancer 144
Deciphering signaling pathways in hematopoietic stem cells: the molecular complexity of Myelodysplastic Syndromes (MDS) and leukemic progression 139
Nuclear PI-PLC β1 and Myelodysplastic Syndromes: From Bench to Clinics 137
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. 137
Nuclear PLCs affect insulin secretion by targeting PPARgamma; in pancreatic beta cells. 119
IPMK and β-catenin take part in PLC-β1-dependent signaling pathway during myogenic differentiation 115
Roles of p53, NF-kappa B and the androgen receptor in controlling NGAL expression in prostate cancer cell lines 98
Nuclear phosphoinositides: location, regulation and function. 89
null 80
Phosphatidylinositol Turnover and Receptors 80
null 78
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells 70
Nuclear phospholipase C in biological control and cancer 69
null 65
Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology. 52
Inositide-dependent signal transduction in the nucleus: a virtuous path from the laboratory to the clinic 49
Totale 13.329
Categoria #
all - tutte 34.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.821


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021372 0 0 0 0 0 0 0 0 0 51 42 279
2021/20221.581 155 35 109 113 133 70 42 99 46 262 266 251
2022/20231.798 199 243 106 254 151 133 119 85 258 32 105 113
2023/2024658 26 91 83 64 69 105 40 31 32 38 31 48
2024/20252.034 87 253 209 127 336 108 188 97 49 112 106 362
2025/20264.125 385 495 424 302 559 250 490 133 850 237 0 0
Totale 13.329